Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit To Export Controlled Substances, Application for Permit To Export Controlled Substances for Subsequent Re-Export; DEA Forms 161, 161R, 161R-EEA, 48267-48268 [2020-17379]

Download as PDF Federal Register / Vol. 85, No. 154 / Monday, August 10, 2020 / Notices Order Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. AL9587330 issued to Tommy L. Louisville, M.D. This Order is effective September 9, 2020. Timothy J. Shea, Acting Administrator. [FR Doc. 2020–17373 Filed 8–7–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0009] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Controlled Substances Import/Export Declaration; DEA Form 236 Drug Enforcement Administration, Department of Justice. ACTION: 30-Day Notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for 30 days until September 9, 2020. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; jbell on DSKJLSW7X2PROD with NOTICES SUMMARY: medical license. The pendency of such an appeal, however, is irrelevant to my decision. See, e.g., James Alvin Chaney, M.D., 80 FR 57391, 57392 (2015) (calling the fact that a state’s suspension order remains subject to challenge ‘‘of no consequence’’ to the Agency’s decision to revoke). VerDate Sep<11>2014 20:31 Aug 07, 2020 Jkt 250001 —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Controlled Substances Import/Export Declaration. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form Number: DEA Form 236. The Department of Justice component is the Drug Enforcement Administration, Office of Diversion Control. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): None. Abstract: DEA Form 236 enables DEA to monitor and control the importation and exportation of controlled substances. Analysis of these documents provides DEA with important intelligence regarding the international commerce in controlled substances and assists in the identification of suspected points of diversion. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: DEA estimates that there are 323 total respondents for this information collection. In total, 323 respondents submit 8154 responses, with each response taking 15 minutes to complete. 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates that this collection takes 2,039 annual burden hours. If additional information is required please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution PO 00000 Frm 00119 Fmt 4703 Sfmt 4703 48267 Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: August 5, 2020. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2020–17377 Filed 8–7–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1117–0004] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Permit To Export Controlled Substances, Application for Permit To Export Controlled Substances for Subsequent Re-Export; DEA Forms 161, 161R, 161R–EEA Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. DATES: Comments are encouraged and will be accepted for additional 30 days until September 9, 2020. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; SUMMARY: E:\FR\FM\10AUN1.SGM 10AUN1 48268 Federal Register / Vol. 85, No. 154 / Monday, August 10, 2020 / Notices —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: August 5, 2020. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2020–17379 Filed 8–7–20; 8:45 am] jbell on DSKJLSW7X2PROD with NOTICES BILLING CODE 4410–09–P Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Application for Permit to Export Controlled Substances; Application for Permit to Export Controlled Substances for Subsequent Re-export. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms: 161, 161R, 161R–EEA. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: Title 21, Code of Federal Regulations (21 CFR), Sections 1312.21 and 1312.22 require that any person who desires to export or re-export controlled substances listed in schedules I or II, any narcotic substance listed in schedules III or IV, or any nonnarcotic substance in schedule III which the Administrator has specifically designated by regulation in § 1312.30, or any non-narcotic substance in schedules IV or V which is also listed in schedule I or II of the Convention on Psychotropic Substances, must have an export permit. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates that 127 respondents, with 7,282 responses annually to this collection. The DEA estimates that it takes .52719 hour to complete the form. 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates that this collection takes 3,839 annual burden hours. If additional information is required please contact: Melody Braswell, VerDate Sep<11>2014 20:31 Aug 07, 2020 Jkt 250001 DEPARTMENT OF JUSTICE [OMB Number 1117–0024] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Reports of Loss or Disappearance of Listed Chemicals and Regulated Transactions in Tableting/Encapsulating Machines; DEA Forms 107 and 452 Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on June 03, 2020, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for an additional 30 days until September 9, 2020. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including SUMMARY: PO 00000 Frm 00120 Fmt 4703 Sfmt 4703 whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Reports of Loss or Disappearance of Listed Chemicals and Regulated Transactions in Tableting/Encapsulating Machines. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Forms 107 and 452. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: Each regulated person is required to report any unusual or excessive loss or disappearance of a listed chemical, and any regulated transaction in a tableting or encapsulating machine, to include any domestic regulated transaction in a tableting or encapsulating machine and any import or export of a tableting or encapsulating machine. 21 U.S.C. 830 (b)(1)(A), (C) and (D); 21 CFR 1310.05(a)(1), (3)–(4); 21 CFR 1310.05(c). Regulated persons include manufacturers, distributors, importers, and exporters of listed chemicals, tableting machines, or encapsulating machines, or persons who serve as brokers or traders for international transactions involving a listed chemical, tableting machine, or encapsulating machine. 21 CFR 1300.02(b). E:\FR\FM\10AUN1.SGM 10AUN1

Agencies

[Federal Register Volume 85, Number 154 (Monday, August 10, 2020)]
[Notices]
[Pages 48267-48268]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17379]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0004]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Application for Permit To Export Controlled Substances, 
Application for Permit To Export Controlled Substances for Subsequent 
Re-Export; DEA Forms 161, 161R, 161R-EEA

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995.

DATES: Comments are encouraged and will be accepted for additional 30 
days until September 9, 2020.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;

[[Page 48268]]

--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Permit to Export 
Controlled Substances; Application for Permit to Export Controlled 
Substances for Subsequent Re-export.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Forms: 161, 161R, 161R-
EEA. The applicable component within the Department of Justice is the 
Drug Enforcement Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: Title 21, Code of Federal Regulations (21 CFR), Sections 
1312.21 and 1312.22 require that any person who desires to export or 
re-export controlled substances listed in schedules I or II, any 
narcotic substance listed in schedules III or IV, or any non-narcotic 
substance in schedule III which the Administrator has specifically 
designated by regulation in Sec.  1312.30, or any non-narcotic 
substance in schedules IV or V which is also listed in schedule I or II 
of the Convention on Psychotropic Substances, must have an export 
permit.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 127 respondents, with 7,282 responses annually to this collection. 
The DEA estimates that it takes .52719 hour to complete the form.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates that this collection 
takes 3,839 annual burden hours.
    If additional information is required please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: August 5, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2020-17379 Filed 8-7-20; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.